StockMarketWire.com - Verona Pharma plc (AIM: VRP.L), the drug development company focused on first-in-class medicines to treat respiratory diseases, has appointed Ken Cunningham and Anders Ullman as non-executive directors.

Dr Cunningham, who has over 25 years experience in the pharmaceutical industry, will replace Professor Jones as the non-executive director appointed by the Wales Life Sciences Investment Fund under the Subscription and Shareholders Agreement entered into in March last year.

Claire Poll, an executive director, and Stuart Bottomley and Professor Trevor Jones, both non-executive directors, will retire from the Verona Pharma Board after having served since 2006. Ms Poll will continue to provide legal and corporate services to the company.






At 10:56am: [LON:VRP] Verona Pharma PLC share price was -0.25p at 4.7p



Story provided by StockMarketWire.com